Cardinal Health's Strategic Acquisitions and Financial Growth Propel Stock Performance
Sat, August 01, 2026Cardinal Health’s Strategic Acquisitions and Financial Growth Propel Stock Performance
Cardinal Health (NYSE: CAH) has recently achieved significant milestones, including strategic acquisitions and robust financial growth, contributing to its strong stock performance.
Completion of Solaris Health Acquisition
In November 2025, Cardinal Health completed the acquisition of Solaris Health, the nation’s leading urology management services organization (MSO). This acquisition added over 750 providers across more than 250 practice locations in 14 states to Cardinal Health’s multi-specialty MSO platform, The Specialty Alliance. This expansion enhances Cardinal Health’s presence in the urology sector and strengthens its position in the integrated healthcare services market.
Financial Performance and Raised Outlook
In the second quarter of fiscal year 2026, Cardinal Health reported a 19% increase in revenue, reaching $65.6 billion. GAAP operating earnings rose by 29% to $707 million, while non-GAAP operating earnings increased by 38% to $877 million. These strong results led the company to raise its fiscal year 2026 non-GAAP EPS guidance to a range of $10.15 to $10.35.
Stock Performance
As of July 31, 2026, Cardinal Health’s stock price reached $230.03, reflecting a 1.49% increase from the previous close. This performance underscores investor confidence in the company’s strategic direction and financial health.
Analyst Perspectives
Analysts have responded positively to Cardinal Health’s performance. Bank of America raised its price target for the stock to $260 from $240, maintaining a ‘Buy’ rating. This adjustment reflects expectations of continued growth and profitability.
Conclusion
Cardinal Health’s strategic acquisitions, particularly the integration of Solaris Health, combined with strong financial performance, have significantly enhanced its market position. These developments have positively influenced the company’s stock performance, reflecting investor confidence in its growth trajectory.